Filing Details
- Accession Number:
- 0001181431-12-054153
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-10-09 16:01:43
- Reporting Period:
- 2012-10-05
- Filing Date:
- 2012-10-09
- Accepted Time:
- 2012-10-09 16:01:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1029142 | Dynavax Technologies Corp | DVAX | Pharmaceutical Preparations (2834) | 330728374 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1278710 | Robert Coffman | C/O Dynavax Technologies 2929 Seventh Street, Suite 100 Berkeley CA 94710 | Chief Scientific Officer & Vp | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | Acquisiton | 2012-10-05 | 2,251 | $1.50 | 43,576 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-10-05 | 695 | $4.86 | 42,881 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2012-10-05 | 1,556 | $4.86 | 41,325 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-10-05 | 3,111 | $4.96 | 0 | No | 4 | S | Indirect | See footnote. |
| Common Stock | Disposition | 2012-10-05 | 3,333 | $4.96 | 37,992 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | See footnote. |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2012-10-05 | 2,251 | $0.00 | 2,251 | $1.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-01-22 | No | 4 | M | Direct |
Footnotes
- The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.
- Not applicable.
- Represents shares held by Robert Coffman and Susan Coffman.
- Shares being exercised pursuant to options vested.
Billionaire Hedge Funds
